Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lalloo

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Familial Cancer|November 27, 2013
Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programmeD Gareth R Evans, Sarah Ingham, Sarah Dawe, et al.
Clinical Genetics|October 10, 2006
Inherited association of breast and colorectal cancer: limited role of CHEK2 compared with high-penetrance genesH Naseem, J Boylan, D Speake, et al.
Familial Cancer|April 3, 2010
RASSF1A polymorphism in familial breast cancerJ Bergqvist, A Latif, S A Roberts, et al.
Journal of Medical Genetics|June 3, 2004
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPROD G R Evans, D M Eccles, N Rahman, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|July 5, 2021
Patient reported outcome measures in a cohort of patients at high risk of breast cancer treated by bilateral risk reducing mastectomy and breast reconstructionA Gandhi, P Duxbury, J Murphy, et al.
Journal of Medical Genetics|May 1, 1991
The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculationsJ Burn, P Chapman, J Delhanty, et al.
Journal of Medical Genetics|June 5, 2015
The BRCA2 polymorphic stop codon: stuff or nonsense?J E Higgs, E F Harkness, N L Bowers, et al.
Journal of Medical Genetics|October 5, 2014
Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC)K Newton, N M Jorgensen, A J Wallace, et al.
Journal of Medical Genetics|November 3, 2006
Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screeningA Smith, A Moran, M C Boyd, et al.
Disease Markers|December 14, 1999
Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative GroupP Møller, M M Reis, G Evans, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Familial Cancer|November 27, 2013
Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programmeD Gareth R Evans, Sarah Ingham, Sarah Dawe, et al.
Clinical Genetics|October 10, 2006
Inherited association of breast and colorectal cancer: limited role of CHEK2 compared with high-penetrance genesH Naseem, J Boylan, D Speake, et al.
Familial Cancer|April 3, 2010
RASSF1A polymorphism in familial breast cancerJ Bergqvist, A Latif, S A Roberts, et al.
Journal of Medical Genetics|June 3, 2004
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPROD G R Evans, D M Eccles, N Rahman, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|July 5, 2021
Patient reported outcome measures in a cohort of patients at high risk of breast cancer treated by bilateral risk reducing mastectomy and breast reconstructionA Gandhi, P Duxbury, J Murphy, et al.
Journal of Medical Genetics|May 1, 1991
The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculationsJ Burn, P Chapman, J Delhanty, et al.
Journal of Medical Genetics|June 5, 2015
The BRCA2 polymorphic stop codon: stuff or nonsense?J E Higgs, E F Harkness, N L Bowers, et al.
Journal of Medical Genetics|October 5, 2014
Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC)K Newton, N M Jorgensen, A J Wallace, et al.
Journal of Medical Genetics|November 3, 2006
Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screeningA Smith, A Moran, M C Boyd, et al.
Disease Markers|December 14, 1999
Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative GroupP Møller, M M Reis, G Evans, et al.
Pageof 7